Alpine Woods Capital Investors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-8,284
Closed -$433K 473
2017
Q3
$433K Hold
8,284
0.02% 334
2017
Q2
$485K Hold
8,284
0.03% 308
2017
Q1
$380K Buy
8,284
+2,667
+47% +$133K 0.02% 343
2016
Q4
$295K Sell
5,617
-3,612
-39% -$175K 0.02% 363
2016
Q3
$411K Buy
9,229
+2,160
+31% +$93.7K 0.02% 333
2016
Q2
$270K Sell
7,069
-2,760
-28% -$121K 0.02% 364
2016
Q1
$405K Buy
9,829
+719
+8% +$29.6K 0.02% 320
2015
Q4
$442K Buy
+9,110
New +$405K 0.02% 331

Other funds holding SYNH

Alpine Woods Capital Investors's SYNH Position: Q4 2017 in Review

Alpine Woods Capital Investors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2017, closing a stake of 8,284 shares — an estimated $433K sold.

Alpine Woods Capital Investors first reported a position in SYNH in Q4 2015 and held it in 8 quarters. The position peaked at $485K in Q2 2017. 194 funds tracked by Wall St. Rank hold SYNH as of Q4 2017.

  • Alpine Woods Capital Investors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2017 after selling out during the quarter.
  • Alpine Woods Capital Investors sold 8,284 Syneos Health, Inc. Class A Common Stock shares in Q4 2017, an estimated $433K.
  • Alpine Woods Capital Investors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 8 quarters.
  • Alpine Woods Capital Investors's Syneos Health, Inc. Class A Common Stock position peaked at $485K in Q2 2017.
  • 194 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2017.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2017, filed 14 Feb 2018.